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ABSTRACT
The CRISPR (clustered regularly interspaced short
palindromic repeats) system protects archaea and
bacteria by eliminating nucleic acid invaders in a
crRNA-guided manner. The Sulfolobus islandicus
type III-B Cmr– system targets invading nucleic acid
at both RNA and DNA levels and DNA targeting relies
on the directional transcription of the protospacer in
vivo. To gain further insight into the involved mech-
anism, we purified a native effector complex of III-
B Cmr– from S. islandicus and characterized it in
vitro. Cmr– cleaved RNAs complementary to crRNA
present in the complex and its ssDNA destruction ac-
tivity was activated by target RNA. The ssDNA cleav-
age required mismatches between the 5′-tag of cr-
RNA and the 3′-flanking region of target RNA. An in-
vader plasmid assay showed that mutation either in
the histidine-aspartate acid (HD) domain (a quadru-
ple mutation) or in the GGDD motif of the Cmr–2
protein resulted in attenuation of the DNA interfer-
ence in vivo. However, double mutation of the HD
motif only abolished the DNase activity in vitro. Fur-
thermore, the activated Cmr– binary complex func-
tioned as a highly active DNase to destroy a large
excess DNA substrate, which could provide a power-
ful means to rapidly degrade replicating viral DNA.
INTRODUCTION
The CRISPR-Cas (clustered regularly interspaced short
palindromic repeats, CRISPR-associated) system provides
an inheritable adaptive immunity against invasion of viruses
or plasmids in archaea and bacteria (1–3). The system is
comprised of two parts: CRISPR loci and cas gene cas-
settes. The former are composed of arrays of short repetitive
DNA sequences (repeats) that are interspaced by unique
DNA segments derived from invading genetic elements
(spacers), whereas the latter encode structural proteins or
enzymes associated with nucleic acids interference (4–8).
All known CRISPR-Cas systems function in three distinct
stages: (i) Adaptation––in which new spacers are acquired
from invading nucleic acids, (ii) crRNA biogenesis––where
CRISPR loci are transcribed and processed into mature
CRISPR RNAs (crRNAs) and (iii) Interference––in which
crRNAs form ribonucleoprotein complexes with Cas pro-
teins, which identify invading nucleic acids for destruction.
At least six different types of CRISPR-Cas systems are
known among which type I, II and III are widely inves-
tigated (3). Characterization of these systems shows that
there is a general conservation in spacer acquisition (9,10),
but the mechanisms of crRNA biogenesis and invader si-
lencing are type-specific (11,12). Type I and II CRISPR-Cas
target dsDNA and their effector complexes distinguish in-
vadingDNAs from selfDNAs by recognition of a shortmo-
tif immediately adjacent to the target sequence (protospacer
adjacent motif, PAM) (13–19). Initial studies on type III-A
and III-B systems showed that the Staphylococcus epider-
midis Csm system mediates DNA interference in vivo, and
the activity is independent of a PAMmotif (20,21) whereas
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in vitro characterization of type III-B effector complexes pu-
rified from Pyrococcus furiosus and Sulfolobus solfataricus
revealed their RNA interference activity (22–24).
A breakthrough in studying the function of type III
CRISPR systems was made in our genetic analysis of a type
III-B CRISPR RAMP module (Cmr) system in Sulfolobus
islandicus. First, we found that the III-B system (Cmr–)
mediates transcription-dependent DNA interference (25)
and subsequently, the same system was shown to confer
RNA interference. Thus the Cmr– system represents the
first dual nucleic acids-targeting CRISPR-Cas system to be
identified (26). Investigation of other type III CRISPR-Cas
effector complexes has also revealed dual DNA/RNA in-
terference, including III-A systems present inS. epidermidis,
Streptococcus thermophilus and Thermus thermophilus (27–
31), the type III-B systems of T. thermophilus and P. fu-
riosus (32–36) and the type III-D system from S. solfatar-
icus (37,38). To date, only two III-B systems are known
to solely mediate RNA interference, including the Cmr7-
containing S. solfataricus Cmr and S. islandicus Cmr- sys-
tems (23,26,38–40).
Here we further characterized the S. islandicus Cmr–
system by purification of its wild-type and mutated effec-
tor complexes from the native host and testing for its DNA
and RNA cleavage activity. We found that, upon activation
by target RNA, the native Cmr– complex exhibits very fast
turnover on ssDNA substrate and is capable of degrading
large amounts of DNA substrate.
MATERIALS AND METHODS
Strains, growth conditions and transformation of Sulfolobus
strains
All Sulfolobus strains were derived from the original isolate
S. islandicus REY15A (41) (Supplementary Table S1). Ge-
netic host E233S1 and the Δcmr- mutant were reported
previously (42,43). S. islandicusMF1 was constructed with
the E233S1 strain in two steps using a CRISPR-assisted
gene deletion/mutagenesis procedure recently developed in
our laboratory (Supplementary Figure S2) (44); (i) the ge-
netic region encompassing the two cassettes of type I-A cas
genes and the two CRISPR arrays was deleted and (ii) the
promoter of csa5 and the coding sequence of cas6 were
fused together, yielding an active cas6 gene. Four cmr-2
mutants were used in this work, two of which, cmr-2-HD-
M1 and -M2 were reported previously (44) whereas cmr-
2Palm-M1 and -M2 strainswere constructed as for the two
cmr-2HD mutants (Supplementary Table S1). Sulfolobus
strains were grown in SCVmedium (basic salts and 0.2% su-
crose, 0.2% casa amino acids, 1% vitamin solution) at 78◦C.
If appropriate, uracil was supplemented to 20g/ml. Trans-
formation was performed by electroporation as previously
described (42).
Construction of plasmids
Protospacer SS1 of the lacS gene was employed for gene
silencing previously using a plasmid carrying an artificial
CRISPR array containing SS1 spacer (26). DNA fragments
of CRISPR array with multiple identical spacers were gen-
erated by polymerase chain reaction (PCR) with SS1-fwd
and SS1-rev (Supplementary Table S3), and the resulting
DNA fragments were digested by SalI and inserted into
pSeSD1 between StuI and SalI sites. The ligation was used
to transform Escherichia coli and the transformants were
screened for the size of CRISPR array by PCR. A plasmid
containing 10 copies of SS1 spacers (pAC10-SS1) was iden-
tified and used as the vector to clone cmr6α.
A C-terminal His-tagged version of cmr6α was obtained
by inserting its coding sequence into the Sulfolobus expres-
sion vector pSeSD1 (45) at NdeI and StuI sites. Then, the
tagged gene was amplified by PCR using the primer pair of
MCS-up andMCS-dw (Supplementary Table S3). The PCR
product was digested with SmaI andXhoI, and inserted into
pAC10-SS1 at SalI and SmaI sites, giving pAC-cmr6.
Plasmids for mutagenesis in the Palm domain of Cmr-
2 were constructed as described previously (44) using the
oligonucleotides listed in Supplementary Table S3.
All the primers to be used for DNA cloning were syn-
thesized from TAG Copenhagen A/S (Copenhagen, Den-
mark). Sequences of all plasmid constructs were verified by
DNA sequencing at the MacroGen Europe (Amsterdam,
Netherlands).
Purification of Cmr– crRNA ribonucleoprotein complex
The expression and purification procedure reported for the
purification of a tagged Cmr- from S. solfataricus (23)
was followed with modification. S. islandicus strains car-
rying a cmr6α expression plasmid were grown in SCV at
78◦C up to A600 = 0.7, and cells were collected from at
least 10 liters of culture by centrifugation at 8000 rpm for
10 min. Cell pellet was re-suspended in Buffer A (20 mM
HEPES pH 7.5, 30 mM Imidazole, 500 mMNaCl) and dis-
rupted by French press. The cell extract was loaded onto
a 1 ml HisTrap HP (GE Healthcare) and His-tagged pro-
tein was eluted by Buffer B (20 mM HEPES pH 7.5, 500
mM Imidazole, 500 mM NaCl). Five milliliters of Buffer
B fractions were concentrated and further purified by size
exclusion chromatography in Buffer C (20 mM Tris-HCl
pH 7.5, 250 mM NaCl) with a Superdex 200 Hiload col-
umn (GE Healthcare). Sample fractions were analyzed by
sodium dodecyl sulphate-polyacrylamide gel electrophore-
sis (SDS-PAGE) and those containing the complete set of
Cmr– components were pooled together and used for fur-
ther analysis.
Extraction and analysis of crRNA from the Cmr– ribonu-
cleoprotein complex
One hundred microliters of purified Cmr– complex were
mixed with 200 l DEPC-H2O, 600 l Trizol agent (Sigma)
and 300 l chloroform in the indicated order. The mix-
ture was incubated at room temperature for 5 min and cen-
trifuged at 12 000 rpm for 10 min. The upper phase was
transferred into a new tube and re-extracted with 300 l
chloroform. RNA in the upper phase was precipitated with
one volume of isopropanol and washed with 1 ml of 75%
ethanol. The pellet was air-dried for 30min at the room tem-
perature and dissolved in 15 l DEPC-H2O, giving crRNA
preparations for further analysis. An aliquot of the purified
crRNA was 5′ labeled with 32P- -ATP (PerkinElmer) us-
ing T4 polynucleotide kinase (New England Biolabs) and
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separated on a 12% denaturing polyacrylamide gel. The la-
beled RNAs were identified by exposing the gel to a phos-
phor screen (GE Healthcare) and scanned with a Typhoon
FLA 7000 (GE Healthcare).
About 1 g of crRNA extracted from the Cmr– com-
plex purified from the wild-type S. islandicus strain was sent
to Beijing Genomics Institute, China for RNA sequencing
using a paired-end sequencing protocol with the maximum
read length of 90 bases. The RNA sample was phosphory-
lated before the analysis since crRNAs carry a 5′-OH group
that are not a direct substrate for the RNA sequencing reac-
tion. The reads were mapped to the genome of S. islandicus
Rey15A (Genbank ID: CP002424) using CLC Genomics
Workbench 7.5 (CLC Genomics, Denmark).
Labeling of DNA and RNA substrates
DNA and RNA substrates used in cleavage assays were 5′
labeled with 32P using T4 polynucleotide kinase (New Eng-
land Biolabs) or 3′ labeled with [32P]pCp (PerkinElmer) us-
ing T4 RNA ligase (Invitrogen). Double strand DNA was
generated by annealing of labeled SS1 ssDNA with unla-
beled SS1T ssDNA; bubble DNA was made by annealing
of labeled SS1 ssDNA and unlabeled S32T ssDNA; R-loop
DNA was made by annealing of labeled SS1 ssDNA, unla-
beled S32* RNA and unlabeled S32T ssDNA (Supplemen-
tary Table S4). For the annealing assay, 50 pmol of labeled
substrate was mixed with an equivalent amount of unla-
beled nucleic acid as indicated in the experiments and in-
cubated at 90◦C for 0.5 min. The mixture was allowed to
slowly cool down to the room temperature.
All nucleic acids were purified by recovering the corre-
sponding bands from either a native polyacrylamide gel (ds-
DNA) or denaturing polyacrylamide gel (ssDNA/RNA)
PAGE. DNA and RNA oligonucleotides to be used as sub-
strate for cleavage assays were purchased from IDT, USA.
RNA cleavage and binding assay and DNA cleavage assay
For both RNA and DNA cleavage assay, the reaction mix-
ture (10 l in total) contains 50 mM Tris-Cl (pH 7,6), 10
mMMgCl2, 5 mMDTT and indicated amount of complex
and substrates. In the DNA cleavage assay, 200 nM (un-
less otherwise indicated) unlabeled RNAwas supplemented
into the reaction mixture to activate DNA cleavage activ-
ity. The reaction was performed at 70◦C and stopped at the
indicated time point by the addition of 2 × RNA loading
dye (New England Biolabs) and cooling on ice. Finally, the
samples were heated for 5 min at 95◦C and then run on 18%
polyacrylamide denaturing gels and visualized by phosphor
imaging.
To test the association of RNA substrates/cleavage prod-
ucts with Cmr–, cleavage reactions were set up and mixed
with 2 × RNA loading dye solution at indicated time
points and the samples were then loaded on a 10% non-
denaturing polyacrylamide gel to detect the formation of
Cmr–-crRNA:target RNA tertiary complexes. RNA lad-
ders were generated by Decade™ Marker RNA (Ambion)
following the instructions, while 10/60 DNA ladders were
purchased from IDT and labeled by 32P with T4 polynu-
cleotide kinase.
RESULTS
Purification of tagged native Cmr– complexes from S. is-
landicus
To purify a native crRNA ribonucleoprotein complex of the
S. islandicus Cmr– system, a His-tagged cmr-6 gene was
inserted into the Sulfolobus expression vector pSeSD1 and
the fusion protein was expressed in strain E233S1. Then, a
native Cmr– effector complex was purified in two-step pu-
rification following the procedure described previously (23).
Nickel affinity chromatography showed only one peak of
UV absorbance (Supplementary Figure S1A), and analyz-
ing fractionated samples collected around the peak by SDS-
PAGE revealed that several of them contained proteins of
apparent sizes matching the six different subunits encoded
by theCmr– system (Supplementary Figure S1B), suggest-
ing that the Cmr– complex was co-purified in the experi-
ment. These fractions were pooled and subjected to size ex-
clusion chromatography in which the largest protein com-
plex eluted at 54 ml (Figure 1A). The UV254 profile of
the gel filtration indicated that only this protein complex
contained nucleic acids (Figure 1A) and SDS-PAGE anal-
ysis showed that fractions 52–57 contained all six Cmr–
 proteins (Cmr–1 to 6) (Figure 1B). To verify crRNA
was indeed present in the protein complex, these fractions
were pooled together and used to analyze the crRNA com-
ponent by Trizol extraction, radiolabeling and denaturing
polyacrylamide gel electrophoresis. RNAs of two different
sizes were detected, differing by 6 nt (Figure 1C). The ex-
tracted RNA sample was sequenced by paired-end RNA
sequencing, and this revealed that >99% sequencing reads
matched the spacer sequences in the two CRISPR arrays of
S. islandicus and that there was a very biased distribution
of the abundance of crRNAs on the chromosomal spac-
ers (Supplementary Figure S2). Furthermore, almost all cr-
RNAs started with the 8 nt repeat tag at the 5′-end and they
are almost exclusively 40 or 46 nt in size regardless of the
lengths of original spacers (Figure 1D), indicating that Cmr
crRNAs in S. islandicus were also processed following the
ruler mechanism as previously reported for P. furiosus and
T. thermophilus Cmr crRNAs (22,32).
RNA sequencing of the S. islandicus Cmr– crRNAs
showed that the crRNAs generated from spacer 32 in Clus-
ter 1 (L1S32) is a dominant species. For this reason, we de-
signed the RNA substrate corresponding to this spacer (S32
RNA) and used it to test nucleic acids cleavage by Cmr–.
Two RNA substrates, S10 and SS1, were designed: the for-
mer of which was designed based on the spacer L2S10 (ar-
ray 2, spacer 10), and the latter was for the artificial spacer
SS1 of the lacS gene, both of which were used in our ge-
netic analyses of the CRISPR-Cas system in S. islandicus.
RNA cleavage of the Cmr– complex was tested with each
of the three RNA substrates. Cmr– only cleaved the S10
substrate but was apparently inactive with either SS1 or
S32 RNA substrate (Figure 2). In addition, initial attempts
failed to detect any DNA cleavage activity of the native ef-
fector complex on any designed DNA substrates.
Since the RNA seq data of the crRNAs present in the
Cmr– complex was not particularly useful in selecting a
proper spacer for in vitro analysis, we decided to construct
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Figure 1. Purification of a tagged native effector complex of Cmr– from Sulfolobus islandicus. (A) UV spectrum of gel filtration chromatography of the
His-tagged Cmr– complex. Blue: UV absorbance at 280 nm; red: UV absorbance at 254 nm. (B) SDS-PAGE of the selected peak fractions after the
size exclusion chromatography. (C) Denaturing gel electrophoresis analysis of 5′-labeled RNA copurified with Cmr–. (D) Histogram illustrating the size
distribution of the mapped crRNA reads.
Figure 2. Native Cmr– purified from the wild-type strain only cleaves S10
target RNA. The 5′-end labelled substrates were incubated with Cmr– at
different concentration (0/25/50/100 ng/l) for 1 h and then separated on
18% denaturing-PAGE gel.
a S. islandicus host-plasmid system to produce a Cmr– ef-
fector complex containing only a single defined crRNA. For
this purpose, themutantS. islandicusMF1was constructed,
lacking the genomic region containing two CRISPR loci
and the interference and adaptation modules of type I-A
CRISPR-Cas system except for the csa5 promoter and the
cas6 coding sequence, which were fused together to produce
a functional Cas6 for crRNA biogenesis (Supplementary
Figure S3A). An expression plasmid was constructed, con-
taining aHis-tagged version of cmr-6 gene and an artificial
mini-CRISPR locus of 10 copies of SS1 repeat-spacer units
(Supplementary Figure S3B). After introducing the plasmid
into theMF1 strain by electroporation, transformants were
obtained and used for producing cell mass for purifying the
native tagged Cmr– complex. Since the purified effector
complex only carried SS1 crRNA, the effector complex was
designated as Cmr–-SS1 and characterized.
RNA cleavage of the S. islandicus Cmr– complex
First, RNA cleavage activity of Cmr–-SS1 was tested us-
ing radiolabeled S10, S32 and SS1. The effector complex
was mixed with each target RNA in 1:1 molar ratio and in-
cubated at 70◦C for 20 min. Analyzing cleavage products
by denaturing polyacrylamide gel electrophoresis showed
that only SS1 RNA substrate was cleaved whereas L2S10
and L1S32 RNAs were not substrates of the effector com-
plex (Supplementary Figure S4). This indicated that com-
plementarity between crRNA and target RNA is required
for the RNase activity of Cmr–.
To characterize the RNA cleavage of Cmr–-SS1 in more
detail, an SS1 target RNA was radiolabeled either at the 5′-
end or at 3′-end and used as substrate to test RNA cleav-
age in time-course experiments. As shown in Figure 3A and
B, four cleavage products were observed already at time 0,
for which all components were mixed together at the room
temperature (RT) and the loading buffer was added ca. 1
min later to quench the reaction. These results indicated
that the thermophilic Cmr– complex is capable of cleav-
ing the target RNA immediately after substrate binding at
RT. In addition, the cleavage started predominantly at site
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Figure 3. Cmr–-SS1 cleaves SS1 substrate at four sites. (A and B) SS1 RNA was labeled at 5′-end or 3′-end respectively. 25 nM of the labelled substrates
were incubated with (+) or without (−) 25 nM of Cmr–-SS1 for the indicated time points. Then, the samples were analyzed by denaturing PAGE. The four
cleavage sites are indicated with arrowheads. (C) Schematic depicting the cleavage sites on SS1 RNA. Note that 3′ labeling introduced one more nucleotide
at the 3′-end of SS1 RNA.
2, and after 2 min the 23- and 17-nt products of 5′-labeled
substrate and the 12-nt product of 3′-labeled substrate were
dominant. After 20 min’s incubation, about 80% of target
RNAwas destructed. All cleavage products were positioned
to the RNA substrate, and they differed in 6 nt from each
other (Figure 3C).
The same samples were also analyzed by non-denaturing
gel electrophoresis to investigate the disassociation of the
products from Cmr– complex. As shown in Figure 4, af-
ter 2 min, the 17-nt product from the 5′-end and the 12-
nt, 18-nt, 24-nt products from the 3′-end were observed at
their corresponding position, suggesting that they could be
released from the complex, while the 23-nt and 29-nt from
the 5′-end were still associated with the complex.
Since 46 nt crRNA is more abundant in the Cmr– com-
plex of the early fractions whereas 40 nt crRNA predomi-
nates those from the later fractions in the gel filtration (Sup-
plementary Figure S5A), we investigated the correlation be-
tween the length of crRNA and the RNA cleavage patterns
using F51 and F56. Whereas more cleavage products were
produced at site 4 for F51 sample, more site 3 products
were obtained with F56 (Supplementary Figure S5C), and
this is consistent with the relative contents of 46 and 40 nt
crRNA in the two fractions. Therefore, the Cmr– com-
plex carrying 46-nt crRNAs could contain one more pair of
Cmr4–Cmr5 compared to those containing 40 nt crRNA,
consistent with the current model of type III-B systems in
which a larger and a smaller effector complexes co-exist, dif-
fering in one pair of Cmr4–Cmr5 proteins (46) and the ac-
tive sites reside on Cmr4 subunits in the complex (36,47).
We quantified the uncleaved target RNA in Figure 3 and
this revealed that ca. 20% of target RNA remained un-
cleaved after 20 min incubation. To study the interaction
between target RNA and Cmr– in more details, they were
mixed in different molar ratios (RNA:Cmr = 1:1, 1:0.5, 1:2
and 1:4) and incubated for 60 min during which samples
were taken and analyzed for RNA cleavage. We found that:
(i) doubling the amount of target RNA in the reaction re-
duced the percentage of uncleaved RNA from 18 to 11%
(Supplementary Figure S6A and B), indicating that the in-
complete cleavage did not result from a contamination of
any non-cleavable RNAs in the substrate, and (ii) adding
excess amounts of Cmr–-SS1 accelerated RNA cleavage at
time 0, but the presence of 2 or 4-fold excess Cmr– complex
did not yield any impact on target RNA cleavage (Supple-
mentary Figure S6C), revealing an interesting feature be-
tween the interaction between Cmr– and its target RNA.
Target RNA-activated DNA cleavage
To investigate DNA cleavage of Cmr–, we designed several
different DNA substrates, including ssDNA, dsDNA, bub-
ble DNA and R-loop DNA, the last of which was used to
mimic the transcription structure (Supplementary Table S4
and Figure S7). Furthermore, the SS1 RNA target was also
included in another R-loopDNA sample tomimic the tran-
script of protospacer. Since all these DNA substrates con-
tain the DNA strand complementary to SS1 crRNA (SS1
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Figure 4. Disassociation of target RNA and cleavage products from the Cmr– complex. RNA cleavage was conducted as described in Figure 3 and
samples withdrawn during incubation were analyzed by non-denaturing polyacrylamide gel electrophoresis.
DNA), this DNA was radio-labeled in order to follow the
DNA cleavage. As shown in Figure 5A, Cmr–-SS1 only
cleaved the R-loop DNA in the presence of the cognate tar-
get RNA. Cleavage of ssDNA, dsDNA and bubble DNA
was then tested in the presence of the cognate target RNA.
This showed that ssDNA and the ssDNA region of bubble
DNA were cleaved whereas dsDNA was not a substrate for
the Cmr– complex (Supplementary Figure S8).
The Cmr– DNase activity was further characterized
with 4 different ssDNA substrates in combination with
three different RNAs. The results showed that DNA shred-
ding occurred for all four ssDNA substrates tested but the
DNase activity showed a strict dependence on the presence
of the SS1 target RNA (Figure 5B), meaning that the ac-
tivation of DNA cleavage by Cmr– requires the comple-
mentarity between its target RNA and the crRNA residing
in Cmr–. Once activated, the Cmr– DNase was active in
shredding all four tested DNA substrates, and the cleavage
sites were mapped to the positions after all thymidine bases
in all tested ssDNA substrates (Supplementary Figure S9).
This indicates that the DNA cleavage might not involve the
recognition of DNA substrate via base paring between the
crRNA and its ssDNA target.
To investigate how target DNA was to be discriminated
by Cmr–, three variants of SS1 target RNA, including SS1
(mismatch at the anti-tag region), SS1-50 (with the anti-
tag sequence) and SS1-40 (lacking the anti-tag region), were
tested for their capability to support the Cmr–DNase ac-
tivity. All the three RNAs were equally cleaved by Cmr––
SS1 (Supplementary Figure S10). However, only SS1 acti-
vated theCmr–DNase (Figure 5C), indicating thatCmr–
not only depends on the binding a cognate RNA to the cr-
RNA, but also on the mismatches between the crRNA and
the target RNA at the anti-tag region to activate the DNase
activity, suggesting that DNA target discrimination occurs
at the RNA level.
Cmr–2 contained the active sites for the DNA interference
Cas10 is the signature protein for type III CRISPR-Cas
systems and this protein is named as Cmr-2 in III-B sys-
tems. The protein contains two conserved motifs, i.e. the
histidine-aspartate acid (HD) nuclease domain and the
GGDD motif in the Palm domain (33,48–51), which were
implicated in DNA cleavage. To investigate the function
of Cmr–2 in the Cmr– DNA interference, two mutants
carrying substitutions in the HD domain reported previ-
ously (44) and two mutants of PALM domains constructed
in this work (Supplementary Table S1) were employed for
invader plasmid assay to test their DNA interference ac-
tivity. As shown in Figure 6A, substitution of H14N and
D15N in the HD nuclease domain of Cmr–2 did not af-
fect the DNA interference by the mutant effector complex,
but a quadruple mutation (H14N, D15N, K19A and I23A)
in the same domain abolished the in vivo DNA targeting.
For the Palm domain, either a double mutation (G666K
and D667K) or octal mutation (662––IYlGGDDiLA––671
to AAlAAAAiAS) in the GGDD motif region inactivated
the DNA interference, indicating that both domains are es-
sential for the in vivo Cmr– DNA interference.
All four mutants were then subjected to purification of
Cmr– effector complex by the affinity purification and
size exclusion chromatography as described for the wild-
type strain. Effector complex was not obtainable from them
except the cmr–2α HDM1 mutant from which the effec-
tor complex Cmr–HDM1 was isolated containing Cmr–
2H14N,D15N. RNA cleavage and DNA cleavage by Cmr–
HD–M1 was then analyzed and compared with the activ-
ities of the wild-type Cmr– complex. We found that, while
both effector complexes showed a similar pattern of RNA
cleavage, DNA cleavage by the mutated Cmr– complex
was attenuated (Figure 6B), reinforcing the conclusion that
both HD and GGDD motifs of Cmr–2 are important for
DNA interference in vivo by the CRISPR-Cas system.
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Figure 5. Target RNA activates the ssDNA cleavage activity of Cmr–. (A) ssDNA, dsDNA, bubble DNA, R-loop and R-loop together with 200 nM of
SS1RNAwere incubated with (+) or without (−) 50 nMof Cmr–-SS1 for 1 h. Then, the samples were analyzed by denaturing PAGE. (B) Different labeled
ssDNA substrates (25 nM) were incubated with 50 nM Cmr– in the presence of 200 nM of different ssRNA for 1 h and then analyzed by denaturing
PAGE. (C) Requirement of the non-complementary 3′-flanking region of the target RNA for DNA cleavage activity. A total of 25 nM of labeled SS1
ssDNA substrate was incubated with 50 nM Cmr– in the presence of 200 nM of indicated ssRNA for 1 h and then analyzed by denaturing PAGE.
Large excess amounts of DNA substrate greatly accelerate
DNA cleavage by Cmr–
To further characterize DNA cleavage by Cmr–, 25 nM
labeled SS1 or S10 ssDNA was mixed with a 10-fold ex-
cess of unlabeled SS1, S10 or S32 ssDNA (250 nM) and
tested for the DNase activity. As shown in Supplementary
Figure S11, Cmr– DNase cleaved similar amounts of la-
beled SS1 and S10 ssDNA regardless whether there was
10-fold extra unlabeled ssDNA in the reaction or not, sug-
gesting that increasing DNA substrate concentration could
have accelerated the DNA shredding. This was then investi-
gated systematically by testing DNA destruction in a wide
range of SS1 ssDNA concentrations (25 nM to 50 M),
which were prepared by mixing different amounts of unla-
beled SS1-ssDNA with a constant amount of labeled one
(25 nM). These substrate mixtures were assayed for DNA
cleavage by Cmr-SS1 in the presence of a 4-fold excess of
target RNA (200 nM). As shown in Figure 7A, very simi-
lar patterns of DNA cleavage were observed for substrate
concentrations of 2000-fold difference. Uncleaved ssDNA
was quantitated for each sample and a positive correlation
was seen for the concentrations of the input substrate and
cleaved products (Table 1). More specifically, at the low-
est substrate concentration (25 nM), 17 nM of DNA sub-
strate was cleaved, while 13.6MDNAwas destroyedwhen
the substrate was amounted to 50 M, indicating that the
DNase activity of the same amount of Cmr– complex was
increased for >700-fold (Table 1). To yield an insight into
the superactive DNA cleavage activity, we did a time-course
experiment to compared the dynamics of the cleavage of 25
nM ssDNA substrate with that of 200-fold excess substrate
(25 nM labeled + 5 M unlabeled ssDNA substrate) and
very similar patterns of DNA cleavage were obtained (Fig-
ure 7B). Therefore, we conclude that Cmr– could degrade
a large amount of viral DNA at a low expression level.
DISCUSSION
In this study, a native Cmr– effector complex was purified
from S. islandicus and characterized. The purified complex
contains 6 different subunits, Cmr–1 to 6 that form two
different stoichiometries to accommodate crRNAs of two
different sizes (40 and 46 nt, respectively), which is consis-
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Table 1. ssDNA cleavage with increasing amounts of unlabeled ssDNA substrate
Original SS1 (M) 0.025 0.275 1 5 25 50
Cleaved SS1 (M) 0.017 0.19 0.63 2.76 9.41 13.6
The values of ‘Original SS1’ are the sum of total input substrate including labeled and unlabeled SS1 ssDNA. To obtain the values of ‘Cleaved SS1’, the
residual amount of SS1 substrate was estimated by image quantification for each sample in Figure 7A and deducing the residual SS1 from the total input
value yielded the amount of the cleaved products (Cleaved SS1).
Figure 6. Functional analyses of Cmr-2. (A) In vivo DNA interference
activity of cmr-2 mutants carrying substitutions in the HD or Palm do-
main. pSe-Rp––a repeat cloning vector for Sulfolobus, pS10i––an invader
plasmid carrying a target sequence of spacer 10 in CRISPR locus 2 in
S. islandicus REY15A. Following Cmr2 mutants were used: HD-M1––a
double mutation (H14N, D15N) in the HD domain; HD-M2––a quadru-
ple HD mutation (H14N, D15N, K19A, I23A), Palm-M1––a double mu-
tation (G666K, D667K) in the GGDD motif and Palm-M2––an octal
PALM mutation (662––IYlGGDDiLA––671 to AAlAAAAiAS). (B) In-
vitro RNA/DNA cleavage by the Cmr-2HDM1 effector complex contain-
ing Cmr-2 HDM1 mutant protein. RNA cleavage assay was conducted
with 25 nM labeled SS1 ssRNA, 50 nM Cmr– complex of either the
wild-type (WT) or the mutant complex (HD-M1) harboring Cmr2H14N,
D15N and incubated for 20 min. DNA cleavage was conducted with 25
nM labeled S32T ssDNA substrate, 200 nM SS1 RNA and 50 nMWT or
HD-M1 Cmr– and incubated for 1 h.
tent with the results obtained for III-B Cmr complexes of
T. thermophilus and P. furiosus (32–34,46,47). The natural
species of crRNAs carried by Cmr– complex were gen-
erated from nearly all the spacers from the two CRISPR
arrays. Unexpectedly, the crRNA of L1S32 comprised up
to 69% of the total amounts of crRNAs. Since the RNA
substrate based on L1S32 cannot be cleaved by the Cmr–
 complex, it is more likely that the extremely biased over-
presentation of L1S32 crRNA is due to an artefact occurred
in the RNA sequencing procedure. Apart from the unusual
L1S32 dominance, crRNAs incorporated into the Cmr–
complex still show an uneven distribution among the spac-
ers of the twoCRISPR arrays as their levels can bemounted
up to a difference of 10 000-fold, consistent with the results
obtained from T. thermophilus (32). Recently, the transcrip-
tome ofS. islandicus has been determined byRNA sequenc-
ing (52), showing that CRISPR locus 2 yield higher levels
of crRNA than locus 1, consistent with the distribution of
the crRNA from Cmr– complex in general (Supplemen-
tary Figure S2). However, the transcriptomic analysis also
shows that spacers 1–13, 26–44, 55–63 and 66–72 from lo-
cus 2 and spacers 21–22 from locus 1 are expressed in higher
abundance, which is different from our RNA sequencing
data, suggesting that the maturation and incorporation of
crRNAs are also biased.
Among all known CRISPR-Cas systems, those of type
III exhibit a huge diversity in sequence similarity and sub-
unit composition (1,53) such that the original discoveries of
a III-A Csm system conferring DNA interference (20,21)
and III-B Cmr systems possessing RNA cleavage activity
(22–24) were considered as a general distinction between
the two subclasses. This view was first challenged by the
discovery of the transcription-dependent DNA interference
and dual DNA/RNA targeting by the S. islandicus Cmr–
(type III-B, SisCmr–) (25,26). Subsequently, dual nucleic
acid interference has been demonstrated for the S. epider-
midis Csm (type III-A, SeCsm) (27,30) and the P. furiosus
III-B Cmr system (PfuCmr) (54). Moreover, in vitro studies
show that several III CRISPR-Cas systems showbothRNA
and DNA cleavage activities including the reconstituted T.
maritima III-B Cmr (TmCmr), PfuCmr, SeCsm, StCsm and
SsoCsm (30,31,38,54,55), the last of which is also classified
as a III-D system (53). Here we show that these general re-
sults also apply for the S. islandicus Cmr– system, sug-
gesting that most type III CRISPR-Cas systems possess the
RNA-activated DNA targeting activity although the activ-
ity remains to be tested for SeCsm and SsoCsm. The only
known exceptions are the closely related S. solfataricusCmr
(23,39) and S. islandicus Cmr- (26), which only exhibit
RNA interference.
Characterization of a few III-A, III-B and III-D systems
in vitro (30,31,38,54,55) clearly indicates that Cas10 bears
the active sites for DNA cleavage for type III CRISPR-Cas
systems, i.e. the HD nuclease domain and GGDD motif
in the Palm domain. So far, P. furiosus Cmr2 is the only
Cas10 protein for which both domains have been function-
ally characterized in vivo and in vitro (54). The authors
found that alanine substitutions of HDmotif of Cmr2 abol-
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Figure 7. ssDNA substrate accelerated DNA cleavage of Cmr––SS1. (A) 25 nM of labeled SS1 ssDNA substrate, as well as unlabeled SS1 ssDNA at the
indicated concentrations, were incubated with 50 nM Cmr––SS1 and 200 nM SS1 RNA at 70◦C for 1 h. Then, the samples were analyzed by denaturing
PAGE. (B) 25 nM of labeled S10 ssDNA substrate was incubated with 50 nM Cmr––SS1 and 200 nM SS1 RNA, in the presence or absence of 5 M
unlabeled S10 ssDNA for 1 h during which aliquots of samples were taken at indicated time points, cleavage reactions were stopped by adding 2× loading
buffer and analyzed by denaturing PAGE.
ishes the DNA cleavage by the mutant Cmr complex in vitro
but the same substitutions for DD in the GGDD motif of
the protein does not affect the DNA cleavage, however, mu-
tations in both motifs are required to silence the DNA in-
terference assayed by invader plasmid (54). We found that
while H14N and D15N substitutions (HDM1) in Cmr–2
abolished the DNA cleavage of the mutant Cmr– complex
in vitro, the system still functions in DNA interference in
vivo as plasmid transformation rates were very similar for
the wild-type strain and the mutant. This either suggests
that the mutated H14N D15N motif could still function in
vivo or there could be another active site of DNA cleavage
in Cmr–2, such as the GGDD motif in the Palm domain.
The latter scenario is likely to be true since the Palm do-
main of PfuCmr and SeCsm functions as an active site of
DNA interference (30,54). Interestingly, we found that sub-
stitution of additional two conserved amino acids (K19A
and I23A) in the HD domain, i.e. a quadruple mutation in
the Cmr–2HD domain (HD-M2) attenuated the SisCmr–
 in vivo DNA targeting (Figure 6A). The mutant complex
is very likely to be inactive in vitro since it carries the HD
mutation that abolishes the DNA cleavage activity in the
Cmr–HDM1 complex. This was not tested thus far because
our attempts failed to purify a Cmr– complex from the
HDM2mutant by the Cmr-6 co-purification. Furthermore,
Cmr– complex was not obtainable from two Palmmutants
of Cmr–2, including a double and an octal mutation in
the Palm domain (PalmM1 or PalmM2). This could be due
to that the resulting Cmr– complexes were either less sta-
ble than the wild-type one such that the components disas-
sociated during purification, alternatively Cmr– subunits
could also lost the capability of forming the effector com-
plex in vivo. In each scenario, this suggests both HD and
Palm domains of Cmr2– play a structural role in main-
taining the integrity of the effector complex.
The importance of the mismatch between the target and
crRNA for type III DNA interference was first demon-
strated for SeCsm (21). The same principle also functions in
SisCmr– (25) as revealed from its in vivo analysis and this
was further confirmed by the in vitro study of SeCsm (30).
However, analysis of PfuCmr indicates that the self versus
non-self DNAdistinction occurs at RNA level (54).We also
investigated how the Cmr– system distinguishes target and
non-target nucleic acids in vitro and found that it is the mis-
match between the 5′-handle of crRNA and 3′-sequence
of the target RNA that triggers the RNA-activated Cmr–
 DNase and removing the sequence corresponding to the
5′-handle inactivates the DNase, which is consistent with
the results obtained with StCsm (31), but different from the
results obtained with TmCmr systems (55), suggesting a di-
versification in molecular mechanisms of DNA interference
by type III systems. Indeed, SisCmr– cleaves ssDNA after
thymidine nucleotides, in a similar fashion as observed with
the reconstituted TmCmr (55); PfuCmr also cleaves dsDNA
(54), further arguing for functional diversification of type
III CRISPR-Cas systems as predicted from bioinformatics
analyses (1,53).
Another common feature for type III systems is that they
often coexist with other systems (type I or II) (1), suggest-
ing that type III and I/II CRISPR-Cas systems have their
preferable nucleic acid targets in antivirus immunity. In-
deed, different from type I and II systems, a number of
type III CRISPR-Cas systems showRNA-activated generic
DNA degradation that is not based on base-pairing be-
tween crRNA and DNA substrate. Here we have unrav-
eled a unique feature for the DNA cleavage; the turnover
of ssDNA cleavage by Cmr– is very fast and an increase
of up to 700-fold of Cmr– DNase has been observed
for 1 h incubation. Interestingly, transcriptome analyses of
genome expression in S. islandicus LAL14/1 and REY15A
have revealed that whereas type I genes are significantly up-
regulated after virus infection, type III genes are not in-
duced or even repressed (52,56,57). This raises an important
question as to what role type III CRISPR-Cas systems play
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in the arms race between microbial hosts and their viruses
during evolution. Since it takes time from infection of a new
virus to the acquisition of new spacers and eventually the
production of functional antiviral effector complexes, the
lag between the virus invasion and the onset of CRISPR
immunity against the new virus should allow virus to repli-
cate, producing massive replication intermediates. Indeed,
recently it has been shown that the Sulfolobus SIRV2 virus
produces an exceptionally large amount of ssDNA inter-
mediates (58), a phenomenon that have not been observed
for other Sulfolobus viruses such as fuselloviruses and their
satellites (59,60). Therefore, the capability of massive ss-
DNA destruction by type III immunity would greatly limit
the replication of SIRV2-like viruses whereas the DNA in-
terference by the type I-A system would not be effective. In
this regard, it is advantageous to have different CRISPR-
Cas systems in an organism to lead the arms race toward
the microbe side during evolution.
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